VanEck Associates’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,216
| Closed | -$1.53M | – | 1472 |
|
|
2022
Q3 | $1.53M | Buy |
6,216
+332
| +6% | +$81.6K | ﹤0.01% | 700 |
|
|
2022
Q2 | $1.46M | Buy |
5,884
+420
| +8% | +$104K | ﹤0.01% | 718 |
|
|
2022
Q1 | $1.81M | Buy |
5,464
+537
| +11% | +$178K | ﹤0.01% | 727 |
|
|
2021
Q4 | $1.77M | Buy |
4,927
+837
| +20% | +$301K | ﹤0.01% | 732 |
|
|
2021
Q3 | $1.33M | Buy |
4,090
+352
| +9% | +$115K | ﹤0.01% | 761 |
|
|
2021
Q2 | $1.17M | Buy |
+3,738
| New | +$1.17M | ﹤0.01% | 776 |
|
|
2020
Q2 | – | Sell |
-2,253
| Closed | -$327K | – | 1037 |
|
|
2020
Q1 | $327K | Buy |
2,253
+210
| +10% | +$30.5K | ﹤0.01% | 737 |
|
|
2019
Q4 | $349K | Buy |
+2,043
| New | +$349K | ﹤0.01% | 772 |
|